Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Polymyxin B (500000IU) Injection
Therapeutic Category
Antibacterials, Antibiotic
Dosage Form
Injection
Packaging Type
Vial
Packaging
500000 IU
Price
₹2400/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Polyflip B Injection contains Polymyxin B (500,000 IU), a potent antibiotic used for treating severe bacterial infections caused by multidrug-resistant Gram-negative bacteria. It is particularly effective against Pseudomonas aeruginosa, Acinetobacter baumannii, and Klebsiella pneumoniae, which can cause life-threatening hospital-acquired infections.
Polymyxin B works by disrupting bacterial cell membranes, leading to bacterial cell death. Due to its strong bactericidal properties, it is primarily reserved for critically ill patients when other antibiotics fail.
This injection is commonly used in septicemia, pneumonia, urinary tract infections (UTIs), meningitis, and peritonitis. Since it carries a risk of nephrotoxicity and neurotoxicity, its use is closely monitored in clinical settings.
May cause kidney toxicity, nerve damage, dizziness, muscle weakness, and injection site reactions.
For the treatment of severe Gram-negative bacterial infections, including sepsis, pneumonia, UTIs, and meningitis.
Use only under medical supervision, with dosage monitoring to minimize toxicity risks.
Store at 2°C to 8°C, away from light and moisture. Do not freeze.
Composition : Ofloxacin (0.3% w/v) + Ketorolac (0.5% w/v)
Composition : Moxifloxacin (0.5% w/v)
Composition : Tobramycin (0.3% w/v)
Composition : Flurbiprofen (0.03% w/v) + Gatifloxacin (0.3% w/v)
Composition : Gatifloxacin (0.3% w/v)
Composition : Moxifloxacin (0.5% w/v) + Prednisolone (1% w/v)
Composition : Moxifloxacin (0.5% w/v) + Difluprednate (0.05% w/v)
Composition : Moxifloxacin (0.5% w/v) + Dexamethasone (0.1% w/v)
Composition : Moxifloxacin (5% w/v) + Betamethasone (0.1% w/v)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Polymyxin B 500,000 IU Injection has strong demand in the critical care, infectious disease, hospital care, and intensive care segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on advanced injectable antibiotic portfolios.
Medical distributors and agencies can benefit from consistent demand for serious bacterial infection management under specialist medical supervision. Polymyxin B 500,000 IU is a potent antibiotic used against certain multidrug-resistant Gram-negative bacterial infections Commonly prescribed for severe hospital-acquired infections, bloodstream infections, respiratory tract infections, urinary tract infections, and other complicated bacterial infections as advised by healthcare professionals Often reserved for use in critical care settings where resistant organisms are suspected or confirmed Frequently utilized in intensive care units (ICUs), tertiary care hospitals, and specialty infection management programs Widely prescribed by intensivists, infectious disease specialists, pulmonologists, nephrologists, and physicians This strengthens a comprehensive critical care and anti-infective portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Polymyxin B 500,000 IU Injection with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong hospital demand, institutional procurement, specialty care usage, reliable supply chain support, and attractive margins in the critical care antibiotic segment.
Interested distributors, stockists, and wholesalers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality product ranges, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.